Up next

Autoplay

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

2 Views • 08/04/23
Share
Embed
administrator
administrator
Subscribers
0

Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay